Loading...
XLON
IDHC
Market cap220mUSD
Apr 04, Last price  
0.38USD
1D
0.00%
1Q
-17.39%
Jan 2017
-54.93%
IPO
-73.79%
Name

Integrated Diagnostics Holdings PLC

Chart & Performance

D1W1MN
P/E
21.88
P/S
2.71
EPS
0.88
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
16.49%
Revenues
4.12b
+14.35%
641,595,747671,583,450860,231,4311,014,844,0001,170,621,0001,514,257,0001,921,452,0002,226,495,0002,656,264,0005,224,712,0003,605,047,0004,122,506,000
Net income
510m
-5.69%
24,641,81162,095,022132,768,888144,873,000260,399,000374,023,000502,092,000510,931,000594,015,0001,412,609,000541,110,000510,304,000
CFO
544m
+160.46%
639,095,868209,290,684301,587,025189,862,000398,658,000403,075,000556,308,000697,414,000882,515,0002,269,845,000208,729,000543,663,000
Dividend
Jun 16, 20220.116 USD/sh
Earnings
May 29, 2025

Profile

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
URL
https://www.idhcorp.com/
IPO date
May 06, 2015
Employees
6,718
Domiciled in
JE
Incorporated in
JE

Valuation

Title
EGP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,122,506
14.35%
3,605,047
-31.00%
Cost of revenue
2,999,550
2,502,367
Unusual Expense (Income)
NOPBT
1,122,956
1,102,680
NOPBT Margin
27.24%
30.59%
Operating Taxes
268,993
327,064
Tax Rate
23.95%
29.66%
NOPAT
853,963
775,616
Net income
510,304
-5.69%
541,110
-61.69%
Dividends
(1,411,752)
Dividend yield
371.12%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
220,384
22,675
Long-term debt
2,026,869
1,156,647
Deferred revenue
Other long-term liabilities
435,273
968,710
Net debt
1,386,745
512,746
Cash flow
Cash from operating activities
543,663
208,729
CAPEX
(323,439)
(308,838)
Cash from investing activities
(243,942)
990,113
Cash from financing activities
(330,461)
(1,617,687)
FCF
555,122
350,619
Balance
Cash
860,508
815,916
Long term investments
(149,340)
Excess cash
654,383
486,324
Stockholders' equity
3,527,909
2,148,466
Invested Capital
4,060,877
2,892,938
ROIC
24.56%
29.18%
ROCE
23.82%
29.79%
EV
Common stock shares outstanding
600,000
600,000
Price
0.36
-44.01%
0.63
-50.66%
Market cap
213,000
-44.01%
380,400
-50.66%
EV
2,774,867
1,966,863
EBITDA
1,524,194
1,420,023
EV/EBITDA
1.82
1.39
Interest
141,688
122,677
Interest/NOPBT
12.62%
11.13%